1.77

1.39% -0.03

Hillevax Inc (HLVX)

Overview News Price History Financials Discussions Forecast

Hillevax Inc stock is traded at $1.77, with a volume of 26,824. It is down -1.39% in the last 24 hours and down -8.51% over the past month. HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.

Previous Close:

$1.80

Open:

$1.8

24h Volume:

26,824

Relative Volume:

0.11

Market Cap:

$89.65M

Revenue:

Net Income/Loss:

$-123.57M

P/E Ratio:

-0.5822

EPS:

-3.04

Net Cash Flow:

$-97.53M

1W Performance:

-3.01%

1M Performance:

-8.51%

6M Performance:

-7.07%

1Y Performance:

-89.67%

1-Day Range:

$1.77

$1.80

1-Week Range:

$1.77

$1.88

52-Week Range:

$1.55

$20.22

Hillevax Inc Stock (HLVX) Company Profile

Name

Hillevax Inc

Sector

Healthcare (1189)

Industry

Biotechnology (675)

Phone

(617) 213-5054

Address

321 HARRISON AVE, SUITE 500, BOSTON

Employee

Twitter

Next Earnings Date

Latest SEC Filings

HLVX's Discussions on Twitter

Compare HLVX with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
HLVX Hillevax Inc	1.775	89.65M	0	-123.57M	-97.53M	-3.04
VRTX Vertex Pharmaceuticals Inc	477.45	121.85B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	698.03	76.83B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	618.58	37.96B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	242.53	30.69B	2.25B	-278.16M	-42.59M	-2.17
ONC Beone Medicines Ltd Adr	269.23	29.71B	3.32B	-860.46M	-1.04B	-8.32

Hillevax Inc Stock (HLVX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-09-24	Downgrade	H.C. Wainwright	Buy → Neutral
Jul-09-24	Downgrade	Leerink Partners	Outperform → Market Perform
Jul-09-24	Downgrade	Stifel	Buy → Hold
Jul-08-24	Downgrade	Guggenheim	Buy → Neutral
Jul-08-24	Downgrade	JP Morgan	Overweight → Neutral
Dec-13-23	Initiated	H.C. Wainwright	Buy

View All

Hillevax Inc Stock (HLVX) Latest News

Feb 27, 2025

HKVX STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into HilleVax, Inc. and Encourages Investors to Contact the Firm! - ACCESS Newswire

Feb 27, 2025

Feb 17, 2025

Hillevax CFO Shane Maltbie sells $15,116 in stock By Investing.com - Investing.com Nigeria

Feb 17, 2025

Stocks of HilleVax Inc (HLVX) are poised to climb above their peers - SETE News

Feb 17, 2025

Feb 15, 2025

Hillevax CEO Robert Hershberg sells $48,661 in stock - MSN

Feb 15, 2025

HilleVax, Inc. (NASDAQ:HLVX) Shares Purchased by SG Americas Securities LLC - Defense World

Feb 15, 2025

Feb 13, 2025

Hillevax CFO Shane Maltbie sells $15,116 in stock - MSN

Feb 13, 2025

HilleVax, Inc. (NASDAQ:HLVX) Shares Sold by Qiming U.S. Ventures Management LLC - MarketBeat

Feb 13, 2025

Feb 12, 2025

Top Executives Cash In on HilleVax Stock Sales - TipRanks

Feb 12, 2025

HilleVax Executives Sell Shares in February 2025 - TradingView

Feb 12, 2025

Vitro Diagnostics (OTCMKTS:VODG) vs. HilleVax (NASDAQ:HLVX) Financial Review - Defense World

Feb 12, 2025

Jan 27, 2025

HKVX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into HilleVax, Inc. and Encourages Stockholders to Contact the Firm! - ACCESS Newswire

Jan 27, 2025

Jan 25, 2025

HilleVax, Inc. (NASDAQ:HLVX) Shares Purchased by Barclays PLC - Defense World

Jan 25, 2025

Jan 14, 2025

Jane Street Group LLC Purchases 35,546 Shares of HilleVax, Inc. (NASDAQ:HLVX) - Defense World

Jan 14, 2025

Jan 10, 2025

HilleVax, Inc. (NASDAQ:HLVX) Shares Sold by Geode Capital Management LLC - Defense World

Jan 10, 2025

Barclays PLC Raises Holdings in HilleVax, Inc. (NASDAQ:HLVX) - Defense World

Jan 10, 2025

Jan 07, 2025

Critical Comparison: Zura Bio (NASDAQ:ZURA) versus HilleVax (NASDAQ:HLVX) - Defense World

Jan 07, 2025

Jan 03, 2025

Charles Schwab Investment Management Inc. Has $133,000 Stake in HilleVax, Inc. (NASDAQ:HLVX) - Defense World

Dec 20, 2024

Dec 19, 2024

Critical Survey: Fate Therapeutics (NASDAQ:FATE) versus HilleVax (NASDAQ:HLVX) - Defense World

Dec 19, 2024

Dec 15, 2024

Financial Contrast: Vericel (NASDAQ:VCEL) versus HilleVax (NASDAQ:HLVX) - Defense World

Dec 15, 2024

Dec 10, 2024

HilleVax, Inc. Announces Management Changes - Marketscreener.com

Dec 10, 2024

Dec 09, 2024

3 US Penny Stocks With Market Caps Under $100M - Simply Wall St

Dec 09, 2024

Dec 06, 2024

HilleVax initiates major workforce reduction, executives depart By Investing.com - Investing.com Australia

Dec 06, 2024

Dec 05, 2024

HilleVax initiates major workforce reduction, executives depart - Investing.com

Dec 05, 2024

HilleVax Shares Rise After Announcing Job Cuts, Executive Departures - MarketWatch

Dec 05, 2024

HilleVax, Inc. Announces Workforce Reduction and Leadership Changes - TipRanks

Dec 05, 2024

Head to Head Survey: HilleVax (NASDAQ:HLVX) versus NKGen Biotech (NYSE:NKGN) - Defense World

Dec 05, 2024

Dec 02, 2024

JP Morgan Downgrades HilleVax (HLVX) - MSN

Dec 02, 2024

Nov 30, 2024

1,064,000 Shares in HilleVax, Inc. (NASDAQ:HLVX) Bought by Braidwell LP - MarketBeat

Nov 30, 2024

Nov 26, 2024

GSA Capital Partners LLP Acquires New Shares in HilleVax, Inc. (NASDAQ:HLVX) - Defense World

Nov 26, 2024

Nov 21, 2024

England's Norovirus Outbreak Peaks Early in 2024 - Precision Vaccinations

Nov 21, 2024

Nov 18, 2024

HilleVax, Inc. (NASDAQ:HLVX) Short Interest Update - MarketBeat

Nov 18, 2024

Nov 09, 2024

HilleVax (NASDAQ:HLVX) Stock Price Down 1.5% on Disappointing Earnings - Defense World

Nov 09, 2024

HilleVax (NASDAQ:HLVX) Stock Price Down 1.5% Following Weak Earnings - MarketBeat

Nov 09, 2024

Nov 08, 2024

HilleVax Reports Q3 Financial Results Amid Strategic Planning - TipRanks

Nov 08, 2024

Nov 07, 2024